To cite this paper use one of the standards below:
The development of resistant strains of Mycobacterium tuberculosis (Mtb) is a big concern, which highlights the need of discovering new antibiotics1. Recent studies investigated molecular targets in earlier steps of peptidoglycan synthesis to discover new drugs for tuberculosis treatment2. These findings led us to select the enzyme UDP-N-acetylenolpyruvoylglucosamine reductase (MurB) due to its essential role in peptidoglycan synthesis and no eukaryote homologue2. Andres and coworkers discovered 4-thiazolidinones as MurB inhibitors at a micromolar level3. This way, we are proposing thiazoline and phthalimide derivatives as MurB inhibitors. Molecular docking studies were performed with MurB4 in complex with the proposed heterocycles with several aromatic substituents (electronic and steric effects) and their precursors, which resulted in more than 150 molecules. Interactions with key residues in MurB catalysis such as Arg176, Glu361 and Ser257 were observed, also theoretical Ki at low micromolar range. These results may guide the discovery of new antibiotics against Mtb.
Con casi 200.000 artículos publicados, Galoá permite a los académicos compartir y descubrir investigaciones de vanguardia a través de nuestra plataforma de publicación académica optimizada y accesible.
Obtenga más información sobre nuestros productos:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Atención: este no es un DOI para el trabajo y, como tal, no se puede usar en Lattes para identificar un trabajo en particular.
Check the link "How to cite" en la página del papel, para ver cómo citar correctamente el papel